A biomarker is a measurable entity that can help detect and treat diseases earlier and more effectively, they also potentially reduce the financial cost pressuring healthcare providers today. Medical imaging could have a great impact on progressive diseases, such as certain types of cancer, atherosclerotic cardiovascular diseases, Alzheimer’s disease and rheumatoid arthritis…. Read More »


Validation of Quantitative Imaging Biomarkers The FDA makes a distinction between white-listing (approval or clearance) of a diagnostic drug or device for commercial purposes and qualification of a measurement itself to be used as a biomarker in clinical trials. Approval is only available after demonstrating the safety and effectiveness of a device or drug. However,…… Read More »


CT Angiography utilizes standard CT scanning techniques with the injection of iodine rich contrast material for diagnosing and evaluating vascular diseases and/or related conditions, such as blockages or aneurysms…… Read More »


CT has a long list of distinct advantages over most of the devices in its field, including its relative low cost, availability, and ease of patient monitoring as well as its popularity among hospitals and healthcare professionals worldwide…… Read More »


CTP has proven efficacy in evaluating stroke, it is the most relevant diagnostic imaging procedure in terms of accessibility, speed, and ability to explore the ischemic penumbra…… Read More »


© 2024 Medcoi LLC, all rights reserved.
go to top